Hong Kong: Asia’s largest healthcare deal rockets on debut

Shares in TigerMed Consulting, the region’s largest healthcare deal of the year so far, rocketed on their debut in Hong Kong on Friday. The secondary listing of the China-based provider of comprehensive biopharmaceutical R&D services closed up 13.3%. The company, which is the country’s largest clinical CRO and already listed in Shenzhen, raised HK$10.7bn (US$1.4bn)…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »